Comment on: Statins and the Joint: Multiple Target for a Global Protection?

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 6, 2011, Pages 588-

  Clockaerts, Stefan ^a,b   Bierma Zeinstra, Sita M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LONG CHAIN FATTY ACID; UNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BONE PLATE; CARTILAGE DEGENERATION; DRUG BIOAVAILABILITY; FIRST PASS EFFECT; HUMAN; LETTER; LIPID COMPOSITION; OBESITY; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIAL FLUID;

BONE AND BONES; CARTILAGE, ARTICULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JOINT DISEASES; LIPID METABOLISM; RETROSPECTIVE STUDIES; SYNOVIAL MEMBRANE;

EID: 79955970711     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.01.004     Document Type: Letter

References (7)

1. Lazzerini P.E., Capecchi P.L., Selvi E., Lorenzini S., Bisogno S., Baldari C.T., et al. Statins and the joint: multiple targets for a global protection?. Semin Arthritis Rheum 2011, 40:430-446.
2. Conaghan P.G., Vanharanta H., Dieppe P.A. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64(11):1539-1541.
3. Davies-Tuck M.L., Hanna F., Davis S.R., Bell R.J., Davison S.L., Wluka A.E., et al. Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women-a prospective cohort study. Arthritis Res Ther 2009, 11(6):R181.
4. Reijman M., Pols H.A., Bergink A.P., Hazes J.M., Belo J.N., Lievense A.M., et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007, 66(2):158-162.
5. Pritchett J.W. Statins and dietary fish oils improve lipid composition in bone marrow and joints. Clin Orthop Relat Res 2007, 456:233-237.
6. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., et al. Statin therapy. LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005, 352(1):29-38.
7. Iannone F., Lapadula G. Obesity and inflammation-targets for OA therapy. Curr Drug Targets 2010, 11(5):586-598.